CASE PRESENTATION
and 0.1 renal) and his weekly creatinine clearance to 58 liters A 55-year-old Greek Canadian, a restaurant owner, devel-(52 liters peritoneal and 6 liters renal). After 3 months, his oped end-stage renal disease secondary to proliferative glomer-NPNA remained low at 0.60 g/kg/day. His uremic symptoms ulonephritis of 3 years' duration. Because he was fatigued, had and hypertension became worse, and he could not achieve a poor appetite with occasional morning nausea, and could not his target weight despite three hypertonic exchanges per day. sleep well, he began continuous ambulatory peritoneal dialysis Average ultrafiltration with 2.5% glucose at four hours was 25 (CAPD) 5 years ago through a surgically implanted Toronto ml, and with 4.25% glucose was 180 ml. Dialysate protein losses Western peritoneal catheter. At that time his weight was 71 kg were 12 g/day and his serum albumin fell to 2.8 g/dl. Because his and body surface area 1.76 m 2 . He had substantial residual renal condition was getting worse, he was transferred to automated function, with a 24-hour creatinine clearance of 9.0 ml/min, a peritoneal dialysis (APD) with 4 ϫ 2.8 liter exchange over nine urea clearance of 4.3 ml/min, and a urine volume of 1100 ml/ hours each night and a three-hour 2.5 liter exchange each day. Initial biochemical investigations showed a serum albumin evening. of 3.5 g/dl (Bromcresol green method); hemoglobin, 10.1 g/dl;
On this regimen, his KT/V was 2.1 and creatinine clearance and hematocrit, 33%. He was started on a "standard" CAPD 60 liters/week. Furthermore, his net ultrafiltration increased, regimen of 2-liter exchanges four times daily. At the end of he attained his target weight and, after six months, his NPNA the second week, clearance measurements with the Adequest had increased to 0.8 g/kg/day, but his serum albumin remained program were as follows: D/P creatinine, 0.85; KT/V (urea), low at 3.1 g/dl. Clinically he felt better. He was able to sleep 2.57 (1.07 renal and 1.5 peritoneal); weekly creatinine clearance well and he resumed working part-time work in his restaurant. In the 1960s and 1970s, clinicians based their definitions of adequacy of dialysis on their clinical acumen (HD). Instead, the main cause for failure of CAPD in Canada currently is inadequate dialysis; 12% of CAPD and a review of classic biochemical parameters such as blood urea, creatinine level, and hematocrit. These papatients fail for this reason versus 8.6% because of peritonitis [2] . Underdialysis is now common among CAPD rameters remain valid, albeit insufficient, criteria for determining the adequacy of dialysis. Symptoms and signs patients because an increasing number have been treated with this technique for more than three years, an interval of underdialysis such as nausea, vomiting, fatigue, weakness, insomnia, and restless legs also should be rigorously over which residual renal function usually declines to zero.
Today's patient, a 55-year-old man with high peritosought in assessing the adequacy of dialysis. These latter criteria can be due to other causes, however, and it is neal permeability (defined by D/P creatinine Ͼ 0.80) was started relatively early on dialysis. That is, his endogedifficult to quantitate them. For these reasons, these symptoms and signs are not sufficient for defining adenous creatinine clearance (C Cr ) was 9.0 ml/min. The low serum albumin (3.5 g/dl) at the start of dialysis might quacy and predicting outcome. Furthermore, one might not recognize underdialysis early if one bases the diagnohave been due to a combination of factors such as proteinuria, about which we have no information, and an sis only on clinical and biochemical parameters, and it might not be possible to "catch up" if the dose of dialysis inadequate protein intake. His clinical symptoms improved and his elevated blood pressure was controlled is not increased soon after underdialysis begins. We therefore need now objective, quantifiable parameters by CAPD. In addition, his appetite improved and he gained weight. By the end of the second year, however, by which we can assess adequacy of dialysis and detect underdialysis before clinical symptoms and signs appear. he again became uremic and hypertension returned; a further decrease in his serum albumin and a decrease in In this presentation I will discuss only three major dialysis-related factors that can predict outcome, and I blood urea indicated low protein intake and confirmed the low NPNA of 0.65 g/kg/day. These changes primarily will discuss the relationship among them: small-solute clearances, nutrition, and fluid/volume control. These reflect the decline in his residual renal function with the resulting inadequate clearance of urea and creatinine.
three factors probably are interrelated, and achieving adequate dialysis requires that we address all three toAn increase in the dialysis solution volume to 10 liters/ day did not improve his symptoms or correct his signifigether. Optimization of all three clearly will improve outcomes for all our CAPD patients. I will not examine cant ultrafiltration failure secondary to his high transport state (that is, fast glucose absorption causing dissipation the effect of cardiovascular disease, lipid abnormalities and their control on dialysis outcome, or issues concernof the osmotic gradient responsible for ultrafiltration).
His clinical condition improved, however, after his ing quality of life, not because they are not important, but because I believe their impact on patient survival dialysis technique was converted to APD, an enhanced type of dialysis with short night exchanges of large voldeserves a separate discussion. umes, and one relatively long (3-hour) exchange during Small-solute clearances the daytime. His urea and creatinine clearances improved, and his fluid status was better controlled. After
The National Cooperative Dialysis Study (NCDS), the first attempt at providing objective parameters of adesix months, his NPNA increased but his serum albumin level remained low. This man's history demonstrates all quacy [5] , showed that parameters derived from urea kinetic modeling (UKM) best describe the adequacy of the points about adequacy of peritoneal dialysis that I will discuss during this Forum, specifically, the clearance hemodialysis. According to that study, indicators of a low morbidity are an NPNA Ͼ 1 g/kg/day, and a timeof small molecules (KT/V urea, WCC), the importance of residual renal function, the central role of malnutriaveraged concentration of BUN Ϸ50 mg/dl. Based on the results of the NCDS study, Gotch and Sargent develtion, the phenomenon of high peritoneal permeability and, finally, the importance of fluid/volume overload and oped the concept of KT/V that integrated efficiency of solute clearance (K), treatment time (T), and patient its control.
When physicians devise regimens for patients with size (V) [6] . This dimensionless measure of fractional clearance of body water for urea has been accepted and chronic renal failure, the treatment is optimal if it eliminates all signs and symptoms of the disease and ensures validated as an index of adequacy for hemodialysis. After establishing that KT/V was a reliable predictor of outthe same life expectancy as they would have in the absence of the disease. With few exceptions, however [3] , come in hemodialysis, it was reasonable to extrapolate these same concepts to the prediction of outcome in the life expectancy of dialysis patients is much shorter than that of an aged-matched population, and the term patients on peritoneal dialysis. In hemodialysis, the rate of solute removal changes during dialysis because the "adequate dialysis" is a compromise that implies an "acceptable outcome," which one hopes will be close to concentration of blood urea decreases during dialysis. In CAPD, because the blood urea concentration is relaoptimal [4]. tively constant, clearance and solute removal stay about the same and are related in a linear fashion. In most CAPD patients, the urea in dialysate and plasma achieve virtual equilibrium. Thus, given the stable blood urea concentration, the drain volume is equivalent to urea removal (KT) [4] . This constant relationship between blood levels and removal rate allows continuous treatments like CAPD to remove the same volume of solute per week as does thrice-weekly hemodialysis sessions, even though the clearance rates are substantially lower: 5 to 10 ml/min for CAPD versus 200 to 300 ml/min for HD [7, 8] . Teehan et al, who first applied the UKM NPNA, and KT/V provide a reasonable basis for uniform prescription of peritoneal dialysis and allow comparison of treatment between patients and centers as well as optimization of dialysis and nutrition during therapy [9] .
work group for the malnourished patient, in whom no other cause of malnutrition is discovered, is to increase Measuring KT/V in PD patients. After repeated measurements of KTrp/V, which includes both the contributhe dose of dialysis by multiplying the target KT/V by the ratio V desired/V actual [13] . tion of the renal (KTr/V) and the peritoneal clearance (KTp/V), the coefficient of variation is 8% [10] . The
Comparing KT/V targets in PD and HD: A paradox. Although it is logical to attempt to extrapolate UKM greatest variability is seen with KTr/V (35%); only moderate variability is seen for KTp/V (7%) [10] . The renal data from patients treated with HD to those treated with PD, it is paradoxical that the typical KT/V delivered to component varies even more widely when the amount of urine excreted in 24 hours is very low (1-2 voidings/ CAPD patients is between 1.2 and 2.4 per week [14] . By HD standards, this figure is well below the accepted level day), in which case calculations of clearance should be based on a 48-hour urine collection.
of 3.0 to 3.6/week; however, numerous comparisons of the two modalities have shown no difference in morbidThe peritoneal component (KTp/V) of KTrp/V varies chiefly because of variations in the calculation of V, ity and mortality. Keshaviah and colleagues have tried to resolve this paradox by invoking the peak concentration that is, the volume of distribution of urea. For practical purposes, this is considered equal to the total-body wahypothesis [15] , which asserts that the success of CAPD is related to its continuous, steady-state nature. If uremic ter, although studies using isotopes of urea found that urea distribution space can be smaller than total-body toxicity is associated with the peak concentration of BUN rather than its time-average value, then in hemodialysis water space by approximately 12% to 14% [11] . Total body water (V) can be estimated as a fixed fraction of patients, for approximately one-half of the week the BUN will exceed the time-average urea concentration body weight (60% of BW for men and 55% of BW for women) or an average of 58% for any individual, or by (TAC). Therefore, for hemodialysis the KT/V would have to be higher than that of CAPD to keep the peak anthropometric formulas such as the Watson formula, which most investigators now consider the method of BUN at the same level and achieve equivalent control of uremia [16] . On the basis of this hypothesis, Keshaviah choice [12] .
Because no agreement has been reached concerning calculated that, for a hemodialysis KT/V of 1.3 per treatment, the corresponding weekly CAPD KT/V is 2.0. the weight to be used in estimating V, different results of KT/V have been reported. In general, estimates of V ( Fig. 1 ) [15] . Other possible reasons why CAPD patients appear to need less urea clearance compared to those based on actual weight should be most accurate when actual and desired (ideal) weight do not differ greatly on hemodialysis include the lack of changes in hydration and blood pH, the high clearance of large or middle [12] . In obese patients (wt Ͼ 20% of ideal BW), V should be calculated using ideal BW [12] . Otherwise, the V will molecules, a less catabolic environment, and better preservation of residual renal function (RRF). be overestimated and KT/V underestimated. In wasted patients, KT/V will be misleadingly high if one uses ac-
The rate of decline in residual renal function appears slower in PD than in HD [17, 18] . Possible reasons for tual body weight for the calculation of V; instead, to derive a KT/V indicative of a dialysis dose related to a this difference are: (1) stable high BUN levels in CAPD; (2) absence of marked fluid shifts permitting hemodyhealthier weight, one should use standard body weight, which can be obtained after calculating V with the Watnamic stability and avoidance of glomerular ischemia; (3) reduced dietary protein intake combined with increased son formula and dividing it by 0.58 [9] . The recommendation of the Dialysis Outcome Quality Initiative (DOQI) protein losses in dialysate; (4) absence of cytokine-medi- [19] . He divided the studies into three groups: those that base KT/V targets on theoretical constructs, proFurthermore, the CANUSA and other studies that suggest that targets of dialysis adequacy correlate with paspective studies using univariate analysis, and prospective studies using multivariate analysis. Recently, however, we retrospectively reviewed 115 anuric CAPD patients in our program and correlated worse comorbidity score, and lower initial KT/V and WCC were associated with a worse survival in their study peritoneal KT/V with outcome ( Fig. 2 ; unpublished data). Those who had a KTp/V of Ͻ1.75 had a significantly of 201 patients [21] . Maiorca and coworkers, who studied 68 prevalent patients over three years, determined that higher mortality rate than did patients whose KTp/V exceeded 1.75 ( Fig. 2) . In other words, there is a minimum older age, peripheral vascular disease, dyslipidemia, arrhythmia, initial serum albumin Ͻ 3.5 g/dl, and weekly peritoneal urea clearance (KTp/V of 1.75) below which mortality is increased. KT/V Ͻ 1.7 were detrimental factors [22] . The presence of residual renal function and a KT/V Ͼ 1.98 were associNot all studies have confirmed the correlation between KT/V and patient outcome [24, 27] . This variability in ated with significantly better survival.
Although not a randomized controlled trial, the CANthe published results is due partially to differences in mended in the late 1970s a weekly creatinine clearance of 100 liters for hemodialysis and 50 liters for peritoneal dialysis [29] . Subsequently, Twardowski and colleagues recommended 40 to 50 liters/1.73 m 2 BSA based on their clinical experience [30] . Arkouche and coworkers found these levels inadequate and proposed higher levels, 60 liters/week/1.73 m 2 BSA [31] . Maiorca et al concluded that, for a KT/V of 1.96, above which survival was excellent, the equivalent WCC was 58 liters [22] . According to the CANUSA study, the higher the creatinine clearance (sum of renal and peritoneal), the better the outcome, and a clearance of 70 liter/1.73 m 2 was associated with a 78% survival at 2 years, the same as a KT/V of Ͼ2.1 [23]. The targets recommended by DOQI for continuous treatments such as CAPD and CCPD (WCC of 60 liters/ 1.73 m 2 ) are slightly lower than the target of WCC Ͼ 70 liters, which one would deduce from the CANUSA study. Selgas et al found that WCC was a much weaker [33] . No consensus exists as to whether urea or creatinine the size of the patient groups, the heterogeneity of the clearance is a better marker of adequacy. In fact, in population, the length of study periods [21], differences about 20% of patients, one finds a distinct dissociation in weight used to calculate V, and the inclusion in the between these two markers [34] . analysis of the risk factors I have noted, the hazards of Discrepancy between KT/V and weekly creatinine which are not proportional. Furthermore, as I will discuss clearance can be due to (1) the different levels of residual later, inclusion in the analysis of "high transporters," renal function, (2) the difference in the rate of equilibrawho though they have high small-solute (especially creattion for urea and creatinine between plasma and the inine) clearances, still have a high mortality rate, makes dialysis solution, and (3) the utilization of different northe interpretation of the correlations more difficult.
malizing constant (that is, V for urea and body surface Based on the results of these studies, the Dialysis Outarea for creatinine). Thus in a group of CAPD patients come Quality Initiative working group [13] and an ad hoc with some residual renal function, renal KTr/V urea concommittee of experts [28] recommended rather arbitrary tributed on average only 17% to the total KTrp/V, minimum clearance targets for CAPD patients, namely, whereas the renal creatinine clearance contributed 35% KT/V Ͼ 2.0 and weekly creatinine clearance Ͼ 60 liters/ to the overall creatinine clearance [35] . This difference 1.73 m 2 . Until our previously mentioned experience with was due to the reabsorption of urea and the secretion anuric CAPD patients is further investigated with proof creatinine in the renal tubules; therefore, early in spective controlled studies, it is reasonable to consider CAPD, when patients have some residual renal function, as equivalent the renal and peritoneal clearances and to it is easier to achieve creatinine clearance targets than compensate for the declining residual renal function by KT/V urea targets. On the contrary, when patients beincreasing the peritoneal dose to achieve the recomcome anuric, it is easier to achieve KT/V urea targets mended target [13] . Are the same target levels approbecause of the slower equilibration of creatinine compriate for patients receiving intermittent peritoneal dialpared to urea. For the same reason, during APD at night, ysis? If, as postulated by the peak concentration when exchanges dwell in the peritoneal cavity over short hypothesis, control of the peak urea nitrogen concentraperiods, urea clearance targets are easier to achieve than tion is critical in preventing uremic toxicity, then intercreatinine targets [36] . The use of a different normalizing mittent peritoneal dialysis requires a higher dose to constant (that is, V for urea and body surface area for maintain the peak concentration below the levels creatinine) is an additional reason for the discrepancy achieved in CAPD. The DOQI recommendation for nocbetween KT/V and WCC. Thus for an obese patient, an turnal intermittent peritoneal dialysis is 2.2 per week for overestimation of V can result in a low KT/V. Body KT/V and 66 liters/1.73 m 2 for WCC [13] . weight changes have less effect on BSA and therefore Let's look for a moment at creatinine clearance targets. Using retrospective comparisons, Boen et al recomon normalized WCC [37] . Mandolfo et al [47] that the Bergströ m formula, which c UNA, urea nitrogen appearance is based on balance studies, should become the standard method.
Because larger patients should have a higher protein intake than smaller patients, it has been a common pracNutrition tice to adjust the PNA to the patient's body weight to The observation that the dose of dialysis is related to create a normalized PNA (NPNA) that can be used for the NPNA (an index of the patient's protein intake and comparison and correlation purposes. However, this norappetite) led Lindsay and Spanner to suggest that in malization process creates significant problems because hemodialysis, good nutritional status, as indicated by a clinicians have not agreed what weight to use for this protein equivalent of nitrogen appearance (PNA) Ͼ 1 calculation. None of the various proposals, or for that g/day, is the major determinant of low morbidity [38] ; matter the nomalization concept itself, has been clinically however, good nutrition cannot be obtained without adevalidated [5, 48] . Thus, if the present, actual body weight quate dialysis, as indicated by a KT/V Ͼ 1.0 per hemodiis used, normalization creates a mathematical bias in alysis session. One can assess nutrition by clinical evaluaobese patients, in whom the NPNA is underestimated, tion, dietary history, anthropometric measurements, and and in the wasted individual in whom NPNA is overestivarious biophysical and biochemical methods. Among mated. Alternatives that have been suggested are: (1) the anthropometric indices, one of the simplest and most using standard body weight (ϭV/0.58), where V is calcuuseful is subjective global assessment, which includes lated by the Watson formula, which takes into account four items: weight loss in the previous six months, anage, gender, height, and weight and (2) desirable body orexia, loss of subcutaneous fat, and assessment of musweight, which is the midpoint of the range associated with cle wasting. According to this method, patients are chargreatest longevity for normal individuals of the same age acterized as well nourished, mildly malnourished, or range, gender, and skeletal frame as the patient. These severely malnourished. This method has been validated weights are published in the actuarial tables of the Metin CAPD patients [39] .
ropolitan Life Insurance Company. Although normalizaThe PNA. In addition to providing the KT/V, urea tion using these techniques provides higher values of kinetic modeling can be used to calculate daily protein NPNA for the obese and lower for the wasted, none of intake based on the amount of urea excreted (urea apthese alternatives has been validated in any published pearance), assuming that the patient is in neutral balstudies; hence we should test their usefulness in prospecance. The protein intake, thus calculated, used to be tive studies. Canaud et al recently proposed normalizing called the protein catabolic rate. However, since the acthe PNA to the lean body mass, because muscle mass tual catabolic rate is 5 to 6 times that of daily protein constitutes the major reserve of endogenous proteins intake [40] , and we do not know whether the patient is and nitrogen fuel within the body, thus establishing a catabolic, a better term is "protein equivalent of nitrogen link between PNA and lean body mass [49] . appearance." Some investigators have found a high corThe NPNA is an important reflection of protein intake relation between actual dietary protein intake, estimated but, measured by various formulas, the correlation coefby food records, and the PNA [41] ; others have noticed ficient between dietary protein intake and NPNA is about a marked discrepancy between the two [42] . 0.6, which is less than impressive [43, 50] . In CAPD, in Table 2 shows the various formulas proposed for the contrast to hemodialysis, in which NPNA is an important calculation of protein intake for urea appearance. [52] and in diabetics. In Selgas' losses. Bergströ m's formula, based on nitrogen balance study, patients with NPNA Ͼ 1 g/kg/day had a lower data among CAPD patients, takes into account the rate of hospitalization compared to those with a value Ͻ greater non-urea nitrogen losses in peritoneal dialysis 1.0 g/kg/day [32] . Harty et al have questioned the validity [44] and therefore yields significantly higher values than of adjusting PNA [48] in light of the failure of NPNA the Randerson formula. The formula presented here [45] to reflect conventional parameters of nutrition in crosssectional analyses of hemodialysis [52] and CAPD padiffers from that in the original publication, which con- plied with regard to obese and wasted patients. Dialysis dose and nutrition. The precise relationship between adequacy of dialysis and nutritional status has remained elusive and is a continuing subject of debate suggests that increasing the dialysis dose has a more salutary effect in CAPD. Bergströ m et al, who analyzed [53] . Uremia commonly leads to anorexia, which generally is thought to be due to the accumulation of toxic pooled data of balanced studies-their own and those of Blumenkrantz et al [59]-found a good correlation compounds that inhibit appetite [44, 54] . In elegant experiments in rats, Bergströ m and colleagues demonstrated between NPNA and KT/V in both hemodialysis and CAPD but a steeper slope in CAPD [44] . that uremic toxins with a molecular weight between 1.0 and 1.5 kD (extracted from both uremic serum and nor-
The finding of a steeper slope for CAPD than hemodialysis supports the peak concentration hypothesis [15] mal urine) suppress appetite [55] ; when these molecules were injected intraperitoneally into normal rats, their and the role of middle molecules as a uremic toxin. Bergströ m and Lindholm also suggested that the release food intake decreased in a dose-related fashion. The CANUSA study recently confirmed that anorectic ureof catabolic cytokines, the development of acidosis between dialysis sessions, and the loss of amino acids during mic patients who reach end-stage disease commonly regain their appetite after initiation of dialysis [53] . This hemodialysis has an even greater impact on catabolism than do protein losses in CAPD patients [60] . Furtherobservation suggests that uremic toxins that cause anorexia are removed by dialysis. It also is common clinical more, glucose absorption can have a protein-sparing effect [35, 60], although Bergströ m and Lindholm could experience that inadequately dialyzed patients have a poor appetite and occasionally a special aversion to meat, find no relationship between the amount of glucose absorbed and the protein or energy intake, nor any differand that sometimes their appetite improves when the dialysis prescription is appropriately modified [56] . On ence in protein/energy intakes, whether the abdomen was empty or filled with dialysis solution. the other hand, well-dialyzed patients feel good and eat well. For years now, but especially for the last 5 to 10 Harty and colleagues challenged the validity of this relationship [35, 48] . First they reported that, although years, investigators have attempted to validate these clinical impressions by establishing a relationship between they observed a correlation between KT/V and NPNA, this relationship did not exist between unadjusted PNA dialysis dose and the amount of dietary protein intake [57] . Establishing such a relationship would be of particuand KT/V. Instead they found only a weak correlation between unadjusted PNA and unadjusted urea clearance lar importance because it would unify two factors, dialysis dose and nutritional status, both of which are strong (KT). Paradoxically, malnourished patients had the highest values for normalized urea clearances (KT/V), propredictors of outcome. Such a relationship would give nutrition a central role and thus would have important ducing a significant but inverse correlation between KT/V and lean body mass [35] . This paradox could be partially therapeutic implications, because one could improve nutrition by increasing dialysis dose.
resolved when, instead of normalizing to actual weight, the clearance was normalized to ideal body weight obIn 1989 Lindsay and Spanner established the relationship between KT/V and NPNA for hemodialysis and tained from the National Health and Nutrition Examination Survey (NHANES) tables; then a weakly positive CAPD patients. They observed that the slope of the relationship was lower among CAPD than hemodialysis correlation emerged between KT/V and some nutritional parameters. Interestingly, in the latter case, the contribupatients. Among hemodialysis patients dialyzed with a cellulosic membrane, the mean slope was 0.61, whereas tion of residual renal function, not the level of peritoneal clearance, was responsible for the positive correlation. among those dialyzed with polyacrylonitrile membranes, the slope was higher (1.08) [38] . Subsequently Lysaght These observations led Harty and colleagues to argue forcefully and convincingly that this relationship is conet al [17] and other investigators [20, 58] confirmed the positive relationship between NPNA and KT/V in CAPD ceptually and mathematically flawed [35] . They pointed out that, because KT/V and NPNA share three compopatients. Contrary to the findings of Lindsay and Spanner [38] , other investigators found that the slope between nents (Table 3) , any relationship between the two must be due, in part, to mathematical coupling. They supported KT/V and NPNA is higher (1.5 to 2.0 ϫ) in CAPD patients than in hemodialysis patients [17, 58] . This observation this contention further when they showed that randomly protein intake was measured. (4) A dissociation in the relationship occurs when PNA is increased or decreased by changes in protein intake [66] . (5) KT/V and NPNA are more closely related in diabetics than in non-diabetics [67] . More than any other evidence, however, longitudinal studies support a physiologic basis for the relationship between NPNA and KT/V. Such studies are not affected by a spurious correlation, because an increase in urea generation due to an increase in KT/V would provide unequivocal evidence of increased production and removal of urea nitrogen. Under these circumstances, an increase in NPNA in the absence of weight protein intake [68] . Of course the strongest support for the influence of dialysis dose on nutritional status would be a correlation between changes in dialysis dose and changes in various nutritional estimates, such as subjecgenerated KT/Vs and NPNAs were strongly correlated tive global assessment (SGA) and lean body mass (or with r values between 0.6 and 0.74. In 1996 Uehlinger serum albumin). showed that this correlation between randomly generated Table 4 provides a summary of several prospective numbers is apparent only when V shows a big variation;
longitudinal studies on the effect of KT/V on NPNA and it is completely absent when V is constant [61] . This sugother nutritional parameters. Lindsay et al, who increased gests that it is not the normalization with a common com-KT/V from 0.59 to 0.9 among eight CAPD patients for ponent per se that introduces the statistical artifact, but three months, observed an improvement in NPNA by rather the variation of the component. The lack of a strong 0.282 g/kg/day [69] . Heimburger and colleagues increased relationship between KT/V urea and other formal meaweekly KT/V from 1.53 to 1.89 in 19 CAPD patients over sures of nutrition contrasts significantly with the strong three months and observed an increase in NPNA and correlation between KT/V and NPNA, and supports the an increase in serum albumin from 2.91 Ϯ 0.41 to 3.05 Ϯ view that, in large part, the correlation (between KT/V 0.43 g/dl, which was not statistically significant [70] . After and NPNA) is mathematical. I should emphasize, howan increase in weekly KT/V in 17 CAPD patients from ever, that these findings do not negate the existence 1.44 to 1.78 for one month, Burkart et al observed an of a physiologic relationship between dialysis dose and increase in NPNA from 0.616 to 0.695 g/kg/day (P Ͻ protein intake; Harty et al also accept this possibility 0.05) and in serum albumin from 3.5 (mean of 3 monthly [25] . Mathematical coupling increases the magnitude of albumin values prior to change) to 3.69 g/dl (3 monthly such a correlation. Unfortunately we have no simple albumin values after change) (P Ͻ 0.035) [71] . Uribarri statistical procedure to test whether an observed relaand coworkers increased weekly KT/V from 1.85 to 2.3 tionship exceeds the purely statistical association [61] .
in 23 patients for 6 months and observed an increase in The following observations support the existence of a serum albumin from 3.55 to 3.83 g/dl, but not of NPNA physiologic relationship between NPNA and KT/V: (1) (0.98 to 1.0 g/kg/day) [72] . By increasing KT/V by 25% In 1993 Blake et al asserted that the relationship between in 40 malnourished CAPD patients, Davies et al halted KT/V and NPNA is not linear but flattens out after a or partially reversed their nutritional decline (improveweekly KT/V of 1.83 [62] (Fig. 3) . Nolph et al [63] and ment in lean body mass), but it took at least 6 months Ronco et al [7, 64] subsequently confirmed this finding.
to see the benefit of intervention [73] . Lynn et al inThese observations suggest that there is a dialysis dose creased KT/V among 10 patients from the previously above which protein intake is dialysis-dose-independent accepted targets of Ͼ1.6 to a new KT/V of 2.81 [74] . and instead will depend on the patient's dietary choices They demonstrated significant increases in NPNA levels [7, 63, 65] . Below this point, however, protein intake of Ͼ1.0 g/kg/day in 9 of 10 patients [74] . These patients should strongly be correlated with dialysis dose. This reverted to baseline NPNA levels four weeks after reobservation probably explains the lack of correlation turning to their original dialysis prescription. Williams that some investigators have observed between NPNA et al prospectively studied 10 patients after change of and KT/V in well-dialyzed patients. (2) Differences exist KT/V from 1.37 to 1.68 for three months. Neither NPNA between the slopes in hemodialysis and CAPD and the nor serum albumin changed significantly [75] . Harty et difference in the slope of patients dialyzed with cellulosic al increased weekly KT/V from 1.5 to 1.8 in 33 patients and those with polyacrylonitrile membranes [38, 44] . (3) for 3 months but could show no increase in NPNA [76] . Prospectively, Malhotra et al increased the KT/V from This relationship was confirmed in balance studies when 1.4 to 2.1 in 37 patients [77] . Appetite improved and trition of dialysis patients is metabolic acidosis which, even when slight, can increase the catabolism of branch-NPNA increased from 0.74 to 0.96 g/kg/day, but the mean serum albumin of the group did not change. In individual chain amino acids (valine, leucine, and isoleucine) and lead to valine depletion that limits protein synthesis. A patients, however, the serum albumin decreased in 18 and increased in 15; those in whom serum albumin increased portion of this uremic malnutrition would respond to increases in small-solute clearance and correction of aciwere younger and had a higher dietary protein intake and BUN after the increase in dialysis dose.
dosis, but a further portion might be related more to defective protein anabolism, secondary to dysfunction Obviously these results are inconclusive. Analysis of the CANUSA results provides the best evidence of the of the growth hormone/IGF-1 endocrine axis. This latter portion might respond better to the administration of effect of urea clearance on nutritional parameters [53] . Thus, after initiation of dialysis, weekly total KT/V inagents such as rHGH or even anabolic steroids than to increases in dialytic dose [78] . creased by 1.5 and weekly total C Cr by 35.6 liters/1.73 m 2 . During the first six months, there was improvement in
The second major type of malnutrition, which might be termed comorbid malnutrition, that is, secondary to the mean subjective global assessment, lean body mass, diabetes, heart failure, chronic inflammation, malignancy, and percentage of lean body mass. The subjective global etc., would not respond to alterations in dialytic dose or assessment increased by 0.72 U (P Ͻ 0.001), the lean even protein intake. Infections are important stimulants body mass by 1.6 kg (P Ͻ 0.001), and the percentage of protein catabolism; these, combined with increased of lean body mass by 1.4% (P ϭ 0.01). However, no protein losses, which vary between 5 and 15 g/day and statistically significant changes were noted in serum albuincrease significantly with peritonitis, can lead to malnumin, PCR, or normalized PCR. This improvement in trition and hypoalbuminemia in CAPD patients [60] . several unrelated markers of nutritional status during Malnutrition in individual patients can be of one type the first six months of CAPD supports the contention or the other or even a mix of these [50] . that improved toxin clearance contributes to improved nutritional status [53] . However, the correlations were Fluid/volume control weak, so non-dialysis factors such as comorbidity likely have an important influence on nutritional status. Serum Low urea clearance and malnutrition/hypoalbuminemia increase the risk of death, while cardiovascular albumin levels, although not influenced by dialysis dose, remained a strong predictor of outcome. This observadeaths are the main cause of mortality in CAPD patients. Therefore, it is logical for us to speculate that low KT/V tion suggests that serum albumin level is influenced more strongly by non-nutritional factors, such as comorbidity and malnutrition increase the risk of death from cardiovascular causes. How might low KT/V values and malnuand peritoneal albumin losses.
Malnutrition. Malnutrition has a complex pathogenetrition modify cardiovascular risk? Harty et al suggest that insufficient clearance returns the patient to the presis and does not depend only on adequacy of dialysis. Hence two major types (or causes) of malnutrition fredialysis uremic milieu and thus increases the likelihood of cardiac dysfunction [25] . However, another possible quently occur together in dialysis patients (Fig. 4) . The first, uremic malnutrition, is related to the uremic disorrelationship ties dialysis adequacy targets and cardiovascular mortality: the relationship between fluid overload der per se [50] . Another contributing factor in the malnu- and hypertension, which leads to atherosclerosis and leftalbumin and low lean body mass, but we do not know whether (in these patients) these indices have the same ventricular hypertrophy [79] . Thus, volume overload can directly affect cardiovascular mortality through the depredictive value as if they were the result of malnutrition. Harty et al found no evidence of excess malnutrition velopment of hypertension and left-ventricular hypertrophy [80] . Nolph et al recficult when anuria supervenes two to four years after the initiation of CAPD. By that time, peritoneal ultrafiltraommended that high transporters may warrant increased clearance and protein intake targets. An alternative extion has declined in as many as 30% of CAPD patients, who then develop fluid retention [83, 84] . Most CAPD planation for the increased mortality rate among high transporters is the low ultrafiltration that leads to fluid patients suffer from fluid overload, as indicated by central wedge pressure measurements and measurements overload, which (when chronic) can lead to left-ventricular hypertrophy and cardiovascular disease [80, 90] . We of plasma cGMP levels-a marker of the hydration state [18, 85, 86] . Charra et al have achieved success in managdo not know the best treatment for high transporters, but volume control likely is important. High transporters ing hypertension through control of extracellular fluid volume [3]; they believe this approach is superior to thus are candidates for nocturnal intermittent PD with short exchanges. This technique leads to better ultrafilpharmacologic control. Also, they have noted that even small increases in fluid volume increase the patient's tration, slightly reduced protein losses, lower glucose absorption, and better protein intake [88] . Whether conresistance to antihypertensive medication.
Patients have been classified into four groups on the version to NIPD will lead to higher survival rates is not known. In an outstanding recent review, Bergströ m and basis of peritoneal transport: low (L), low average (LA), Lindholm described a hypothesis integrating malnutrihigh average (HA), and high transporters (HI) [87] . The tion, cardiac disease, and mortality [91] . high transporters (D/Pcreat Ͼ 0.80) need special attention from the nephrologist. These patients have signifiImproving KT/V in underdialyzed patients cantly lower serum albumin levels and NPNA, and lower body mass than do the other groups [88] . The low albu-
The need for an increase in KT/V becomes critical when the patient becomes anuric; special attention must min level probably is the result of increased protein losses across the peritoneum. Also, these patients have be paid to those of large body size, especially patients who (with respect to peritoneal permeability) are low a low NPNA, disproportionate to the level of KT/V, which might be due to increased use of high-glucose transporters. Before one institutes a change in the dialysis prescription, one must ensure that the patient is solutions that, in turn, decrease appetite.
In the CANUSA study, the two-year patient survival compliant with the dialysis instructions. Blake et al noted that patients ignore 20% to 30% of all prescribed changes probabilities were 91%, 80%, 72%, and 68% for L, LA, HA, and HI, respectively [89] . All groups have low serum in their dialysis treatment plan, and usually the staff cannot detect this [92] . Furthermore, some patients run clearances. (4) The longer a patient stays on automated peritoneal dialysis at night, the better the clearance. (5) the risk of reducing the effective exchange volume when they flush larger volumes (than they have been inIncreasing the number of exchanges over a given period does not always increase clearances and, in patients with structed) during the flush of the lines, either because of ignorance or because they are in a hurry to finish the low peritoneal transport, can even decrease clearances. (6) Many large patients require two daytime exchanges. exchange. Noncompliance that can lead to inadequate dialysis appears to be more frequent in the US than in (7) Tidal PD, in which the peritoneal cavity is not drained completely but a volume of 1.0 to 1.5 liters is left in Canada, and this factor might account, at least in part, for the observed difference in the mortality rate between the peritoneal cavity between exchanges, theoretically is better but has been somewhat disappointing in practice the two countries [92] .
Of the various ways of enhancing peritoneal dialysis, [97] . In trying to optimize dialysis, we should not forget that whatever measures we recommend should be comincreasing the exchange volume is the most critical, least expensive, and least intrusive into the patient's life [93] .
patible with costs and the patient's time availability and quality of life. As Nolph said, our goal must be to offer Schoenfeld et al found that clearance of small molecules increases linearly with intraperitoneal volumes [94] . Kedialysis so that our patients will live comfortably rather than merely live so they can do dialysis [98] . shaviah et al confirmed this observation and found that the fill volumes needed to achieve peak clearance inAlthough the topic of my discussion has been adequacy of CAPD, let me briefly comment on the utility of this creased with increasing body surface area: approximately 2.5 liters for a person of average size and 3.0 to 3.5 concept in patients with severe, chronic renal failure. If maintaining targets of small-solute clearance and good liters for an approximate BSA Ն 2 m 2 [95] . The net ultrafiltration is increased in response to higher volumes nutritional status is critical for the patient on dialysis, it is reasonable to assume that these same targets, especially because of better maintenance of the dialysate-to-plasma glucose concentration gradient. Concerns about the use those established for a continuous therapy like CAPD, are also critical for the patient with declining renal funcof increased volume include risk of hernia, increased glucose absorption from the larger intraperitoneal voltion. In this case dialysis should start when residual renal function falls below the targets. This view is supported ume, increased costs, and diminished quality of life because of the extra time required for dialysis, which leads by the observation that initial KT/V is inversely related to hospital admission rates, number of hospitalization to decreased patient acceptance of the procedure [28] . Finally, urea and creatinine clearances were significantly days [99] , and patient survival [53, 100] . Similarly, nutritional status at the start of dialysis is predictive of longhigher (up to 1.7ϫ) in the supine than the upright position [94, 96] .
term outcome [23] . The DOQI group recommends that patients be advised to initiate some form of dialysis when In the majority of anuric CAPD patients, the "standard" CAPD protocol of four two-liter exchanges per the weekly renal KT/V urea falls below 2.0 unless the patient's edema-free weight is stable, NPNA is above day is not adequate to achieve the recommended smallsolute targets. Accordingly, the physician should modify 0.8 kg/day, and the patient has no clinical symptoms. One has to balance the benefits of this approach against the protocol, taking into account the patient's size and peritoneal permeability. Anuric patients who want to the patient's desire to postpone dialysis as long as possible, and the increased costs and potential risks of dialysis. remain on CAPD require a fifth exchange that can be accomplished in the night with the "night exchanger"
Prospective, controlled studies should establish the potential benefits of the early start before it is widely acQuantum (Baxter). In most cases, however, the patient's dialysis treatment will have to be converted to automated cepted and practiced. Before I conclude, let me make a comment on the peritoneal dialysis, that is, either continuous cyclic peritoneal dialysis (CCPD), with two liters left in the peritostandardization of guidelines. There is no doubt that the practice of peritoneal dialysis varies among centers neal cavity during the daytime or with one or two exchanges during the daytime (enhanced CCPD).
within a country and also among various countries. In a recent survey, Ganz et al revealed a significant variation Certain principles should govern the prescription of automated peritoneal dialysis. (1) The target for KT/V in dialysis practice and, most important, in various laboratory parameters (that is, hemogloblin, albumin, PTH) on intermittent treatments should be higher than that for patients on CAPD. The recent DOQI group recomamong various centers in British Columbia [101] . The DOQI guidelines on adequacy of peritoneal dialysis repmended a KT/V of 2.2 and creatinine clearance of 66 liters/week/1.73 m 2 . (2) If the creatinine clearance target resent the first attempt to develop an approach to decrease discordance among centers and improve patient is maintained when one is switching from CAPD to NIPD, urea clearance targets automatically will be achieved.
outcome. I consider this important effort only the beginning, and I envision regular revisions based on new evi-(3) The same quantity of the total dialysate delivered in larger volumes of fewer exchanges produces better dence in the years to come.
QUESTIONS AND ANSWERS
fect serum albumin levels. There is no doubt that, in large series, CAPD patients have lower mean serum Dr. Nicolaos E. Madias (Chief, Division of Nephrolalbumin levels than do hemodialysis patients. However, ogy, New England Medical Center, Boston, Massachulow serum albumin does not always reflect nutritional setts): You addressed the paradox that patients maintained status. In an excellent study, Kaysen and Schoenfeld on peritoneal dialysis have a life expectancy similar to showed that CAPD patients have reduced catabolism those maintained on hemodialysis despite markedly lower and increased anabolism and therefore their total albu-KT/V values, and you accounted for this paradox by inmin mass does not differ from that in controls [102] . voking the peak concentration hypothesis. Although atAccording to these authors, the main reason for hypoaltractive, this is merely a hypothesis and, after all, there buminemia in CAPD is an increase in the volume of are ample differences between these two modalities.
distribution of the albumin mass. It is almost universally Could you please offer other potential explanations for accepted that, both in hemodialysis and peritoneal dialthis phenomenon?
ysis, hypoalbuminemia is a strong predictor of mortality Dr. Oreopoulos: Other possible explanations include [20, 33, 40] . However, it seems that the level of albumin the stable hydration and blood chemistry in CAPD padoes not have the same effect on outcome in peritoneal tients, the high clearance of large molecules, a better dialysis as in hemodialysis. Thus, whereas in hemodialypreservation of residual renal function, and a less catasis the relative risk (RR) of death was significantly inbolic environment. The weight of hemodialysis patients creased when serum albumin was 3.0 to 3.5 g/dl, in CAPD often fluctuates by 3 to 6 kg between dialyses, while that such an increase in mortality appeared when the albumin of CAPD patients remains constant. Their biochemical concentration was less than 3.0 g/dl [103] . The strongest values increase to a maximum before hemodialysis and single predictor of low serum albumin is high peritoneal decrease dramatically at its end. On the contrary, the permeability that leads to low albumin levels either weight and blood chemistry of CAPD patients do not through the increased protein (albumin) losses or through fluctuate. The CAPD patients definitely have less acidooverhydration and hemodilution of serum albumin [104] . showed that serum albumin is strongly influenced by mm/liter. In hemodialysis, the interaction between blood its role as an inverse acute-phase reactant; both groups and the dialysis membrane produces various cytokines hypothesized that the same patterns of cytokine activathat can be nephrotoxic. Finally, in CAPD, residual renal tion associated with acute-phase reaction also could infunction reportedly declines at a much slower rate than crease vascular and thus peritoneal permeability. Addiit does in patients treated by hemodialysis. All these tional factors that can lead to hypoalbuminemia are differences taken together might explain the similar mordiabetes and cardiovascular disease, which by themselves tality rate between the two treatment modalities, despite lead to increased mortality rates. In patients with these lower clearances of small molecules with CAPD. disorders, hypoalbuminemia is an index of the severity of Dr. Madias: Why does residual renal function decline the disease and not necessarily of malnutrition. Finally, I at a slower rate in CAPD than it does in hemodialysis?
would like to stress that the method of measuring albuDr. Oreopoulos: There are various potential reasons. min can affect serum albumin levels; the most frequently In addition to the release of cytokines during the hemodiused method-the colorimetric test using Bromcresol alysis procedure, CAPD patients have a lower protein green-markedly overestimates albumin levels, whereas intake than do hemodialysis patients. This difference in the Bromcresol purple method gives values that slightly protein intake is accentuated further by peritoneal losses underestimate the true level compared with the "gold of protein during CAPD. Furthermore, CAPD patients standard," which is the nephelometry measurement [40] . are in a continuous state of fluid expansion when comBecause albumin is affected by so many factors, it is not pared with hemodialysis patients [85, 86] . Finally, CAPD as good an index of nutrition as are other nutritional patients do not experience the decreases in blood presparameters. sure that are so frequent during hemodialysis. These Dr. Madias: Would you please comment on the effect factors taken together might contribute to the better of intraperitoneal amino acids on the level of malnutrimaintenance of residual renal function in CAPD patients.
tion in general, and on serum albumin in particular? Dr. Madias: You did not say much about hypoalbumiDr. Oreopoulos: Very early in the history of CAPD, nemia in peritoneal dialysis patients. Is it as ominous a circa 1978, when we recognized that malnutrition was predictor of mortality in peritoneal dialysis as it is in an early complication of CAPD, we suggested replacing hemodialysis? Is it related to underdialysis?
glucose as an osmotic agent with amino acids [107] . In Dr. Oreopoulos: I spoke chiefly about other nutrithis way we could dialyze the patients with amino acid tional indices of malnutrition and did not discuss albumin solutions and simultaneously replace protein losses. Although this was a great idea, it took the industry 15 years levels because many factors other than malnutrition af-to come up with commercial amino-acid-containing solumonths, when total weekly creatinine clearance did not change, the nutritional parameters did not change either. tions. Such solutions are not yet available in the US but have been used for the last 4 to 5 years in Europe Dr. Madias: Mathematical bias notwithstanding, you indicated that in two different populations the relation-(Nutrineal with 1.1% amino acids, Baxter). Dialysis with one or two daily exchanges of Nutrineal for as long ship between KT/V and NPNA was steeper in CAPD than in hemodialysis. What might be the basis for this as four weeks produces a positive nitrogen balance [108] . However, serum albumin increased only minimally. Subdifference? Dr. Oreopoulos: This observation supports the peak sequently, in a large study 71 patients received one to two exchanges with Nutrineal for three months and were concentration hypothesis in that the CAPD patients have constant biochemical values. An intermittent therapy compared with 63 patients who were dialyzed with standard solutions [109] . Even though the differences berequires a higher weekly KT/V to maintain the BUN peaks at or below the steady BUN of CAPD, assuming tween the two groups were not great, a subgroup of malnourished patients treated with amino acids showed a similar protein intake and urea excretion rates. Thus, if elevated BUN peaks are associated with appetite supan increase in serum albumin and improvement in other nutritional parameters. Thus I believe that the use of pression (directly or indirectly), a higher weekly KT/V would be required with an intermittent therapy to yield amino-acid-containing solutions has a place in severely malnourished patients on CAPD.
a given NPNA. The observation also emphasizes the importance of toxic substances of middle or large molecDr. John T. Harrington (Dean, Tufts University School of Medicine, Boston, Massachusetts): Dimitrios, ular weight that can be removed more effectively by peritoneal dialysis than by hemodialysis. thank you for a wonderful review. In your comments about Peter Blake's study, did you say that patients with Dr. Geetha Narayan (Division of Nephrology, St. Elizabeth's Medical Center, Brighton, Massachusetts): I a KT/V less than 1.5 had a good outcome? That finding is at variance with other observations. Could you tell us believe that you said that both the well-nourished and the malnourished groups had the same NPNA when admore about your interpretation of Blake's study?
Dr. Oreopoulos: No, I did not say that, John. Indeed, justed for standardized weight. Could you explain that? Dr. Oreopoulos: Harty et al compared a group of I might not have been clear about that point. Blake found that mortality increases after the KT/V falls below patients who were well nourished and another group of malnourished patients (who had lost weight) and found, 1.5. He could not find a difference in mortality with high levels, however. Actually, what he found makes sense; if as you would expect, that the calculated daily PNA-that is, an expression of the daily protein intake expressed you keep decreasing dialysis dose, eventually the patients will suffer increased morbidity and mortality due to urein grams per day-was higher in the well-nourished group than in the malnourished group [48] . However, mia. However, Blake's cut-off point was lower than that in other studies. All other studies showed increased morwhen they normalized the PNA with the patients' present weight (NPNA, that is, g/kg/day), they found the tality if KT/V falls below 1.8 to 2.0. In Blake's series, the cut-off point was below 1.5. The difference between reverse; that is, the NPNA was higher in the malnourished patients, who had lost body weight, than in the his and other studies might be due to the fact that he did not measure KT/V but merely calculated it; yet, when well-nourished ones. This is a misleading paradox. Dr. Ajay K. Singh (Director of Clinical Nephrology, he re-analyzed the data using the measured KT/V, his original findings remained unchanged. The most likely
Brigham & Women's Hospital, Boston, Massachusetts):
A consensus appears to be emerging in the management explanation is that the number of patients followed was too small for Blake to detect the benefits of higher clearof ESRD patients that hemodialysis rather than peritoneal dialysis is the preferable dialytic option for larger ances on mortality.
Dr. Ronald D. Perrone (Division of Nephrology, patients. In a recent study by your group addressing this issue [110] , I believe you compared patients weighing 80 New England Medical Center): You spoke of the mathematical relationship between KT/V and NPNA because kg or more with a group whose body weight was 60 to 80 kg. Could you elaborate on the findings in that study of the shared variables. Have any good studies looked at the relationship between weekly creatinine clearance, and tell us whether you agree with this emerging consensus? an independent measure of adequacy, and NPNA?
Dr. Oreopoulos: The only study I can quote is the Dr. Oreopoulos: In that study, we compared the survival of CAPD patients whose weight was over 80 kg CANUSA study [23] . During the first six months, because of the initiation of dialysis, total weekly creatinine with those whose weight was less than 60 kg and found no difference in mortality rate between the two groups clearances rose by approximately 30 to 40 liters (provided by dialysis), and there was an increase in the sub- [110] . Unfortunately, we did not have data on their KT/V, but you would expect, would you not, that because the jective global assessment and in lean body mass but not in serum albumin or NPNA. During the subsequent 12 daily dialysis volumes were similar in the two groups, there probably were differences in their KT/Vs. These ual renal function have adequate KT/V and weekly creatinine clearance. After all, 1 ml of GFR provides 10 liters findings are similar to those of Kopple et al, who found that overweight hemodialysis patients, despite lower perof weekly creatinine clearance and 0.25 of weekly KT/V. When the creatinine clearance falls below 1 ml/min or cent urea reduction rates, had better survival rates [111] . Heavier patients might have an advantage in that they if the 24-hour urine volume drops below 100 ml/day on at least two successive occasions, we adjust the dialysis are better nourished to begin with, and this might compensate for the fact that they receive relatively less dialdose and repeat the adequacy test. I want to emphasize again the importance of following up the residual renal ysis. Interestingly, in our study, we found a significantly higher mortality rate in both groups among those pafunction. Dr. Singh: Peter Blake presented some attractive data tients who had lost weight. This brings us back to the central role of nutrition. Another explanation for our on compliance with the peritoneal dialysis prescription when he visited Boston about a year ago. In light of findings would be that the patients with the higher body weights might have had better residual renal function. I the disturbing data on mortality of peritoneal dialysis patients in the United States, it seems crucial to ensure believe that if there is some residual renal function, as during the first year or two of renal replacement therapy, compliance. Blake used questionnaires in his study, but in the individual patient, how do you assess compliance you can treat with CAPD almost any individual irrespective of his or her weight. All problems start when the other than, of course, the "look-them-in-the-eye" test? Dr. Oreopoulos: You should suspect non-compliance patient becomes anuric. In our experience, however, the required KT/V targets need not necessarily be as high every time you find an unexplained increase in serum creatinine in the presence of the same residual creatinine in the anuric patient; we found that, after you provide a KT/V over 1.75, the survival rate is excellent: 80% the clearance. In cases like that, you can measure creatinine in the effluent; if it is 15% greater than the effluent first 2 years. Is it possible that the anuric patient does not need a clearance as high as that in the patient with creatinine value established in the baseline period, you should suspect non-compliance. It would be likely that residual renal function? Confirmation of our observation with prospective studies is required. the patient had been skipping dialysis for some time prior to collection and that on the day of the collection Dr. Singh: There appears to be a striking correlation between membrane permeability characteristics and morwas washing out the accumulated creatinine. I believe that the "look-them-in-the-eye" test is a good and relitality. This relationship would suggest that peritoneal equilibration test (PET) studies should become an inteable measure. The question, "Do you do all dialysis exchanges?" emphasizes the importance of complying with gral and early part of the evaluation and management of virtually every PD patient. Can you tell us about your the prescription. Even if patients lie, at least they get the message. It is interesting that Blake relied on an practice?
Dr. Oreopoulos: I will tell you what we are doing in anonymous questionnaire [92] . He assumed that the patients would tell the truth anonymously, but that assumpour unit and what are the DOQI recommendations. We do an Adequest, which provides measurement of PET, tion is open to criticism. Interestingly, he found a greater degree of non-compliance in the US than in Canada; KT/V, weekly creatinine clearance (WCC), and NPNA in each of our new patients; we do not do it during this difference might explain some of the observed difference in mortality rates between the two populations [113, the first two to three weeks of CAPD, because a PET performed within the first week after initiation of perito-114]. In this area, Bernardini and Piraino and colleagues provided the gold standard [115] . They went to their neal dialysis can yield a higher transport result than would a PET performed a few weeks later [112] . The patients' houses and measured the dialysate inventory. They compared the actual number of bags with the num-DOQI recommends that we obtain baseline measurements of KT/V and creatinine clearance two or three ber that the patient should have on hand if the patient is compliant with the dialysis regimen. They also found times during the first six months, and thus obtain a solid baseline value, and then measure these parameters every that a large percentage of their patients were noncompliant. I believe that the companies that deliver the dialysis 6 to 12 months thereafter. However, all one needs to measure in the followup is the creatinine and urea in solutions might be able to help us in this respect by doing a monthly inventory. peritoneal effluent and urine. Repeating the PET is unnecessary because usually it does not change. Dr. Madias: What do you recommend when you enhigher mortality rate among CAPD patients in the US is that during the years 1987 to 1989, very few nephrologists counter discordance between the two indices-KT/V and creatinine clearance?
were concerned about dialysis dose. All patients had the "standard" scheme of 4 ϫ 2-liter exchanges per day, Dr. Oreopoulos: In responding to this difficult question, I will tell you what the DOQI recommends and what irrespective of their residual renal function and peritoneal permeability. The concepts about dialysis dose I am doing in my unit. The DOQI recommends that you try to achieve both targets. If you achieve only one of started to enter our regular practice only in the early nineties. Indeed, when Vonesh and Moran looked at the two, continue with treatment but watch the patient carefully. In anuric patients and those on short exchanges the USRDS results in subsequent years, they found an improvement in the results [116] . They also noted that, with APD, it is easier to achieve KT/V targets than creatinine clearance targets. On the contrary, in those at least for male patients, mortality rates for CAPD during recent years were similar to hemodialysis. with some residual renal function, you can achieve creatinine clearance easier than KT/V. The hemodialysis comDr. Harrington: You used the phrase, as does everyone in the field, "adequacy" of CAPD. Rather than aimmunity always works with urea targets, so I tend to be satisfied that I am doing a good job if my patients have ing for "adequate" CAPD therapy, what alterations would you envision in CAPD solutions, connections, etc., an adequate KT/V, and I do not worry too much about the creatinine clearance targets.
if we were aiming to optimize CAPD? Dr. Oreopoulos: Even though we should continue to Dr. Madias: You mentioned that the survival of CAPD patients is similar to that of hemodialysis patients. But work hard to achieve adequate clearances for our patients, we need better dialysis solutions, and a tremenanalysis of the USRDS data showed that the mortality rate was higher among CAPD patients. Also, undergoing dous effort has been made in the last few years to develop them. We have great difficulty in maintaining our perito-CAPD in the US was a risk factor for mortality in the CANUSA study. Could you please comment on these neal dialysis patients over long periods. We all have patients who have been on CAPD for four to five years. issues?
Dr. Oreopoulos: Nick is referring to the article by However, only a few patients have been on CAPD for more than 10 years. Only one of my patients has been Bloembergen et al [113] . These authors studied a cohort of CAPD patients during the period of 1987 to 1989 and on CAPD for almost 20 years. In any event, these longterm survivors are an exception. I believe this is because indeed found a higher mortality rate among the CAPD patients than in hemodialysis patients, especially among the peritoneal membrane undergoes deleterious alterations when it is exposed to the solutions currently used elderly diabetics. This study had a rather unusual methodology in that it treated each patient as a new patient over long periods. These changes lead on the one hand to poor ultrafiltration and on the other to impairment each year and defined their therapeutic modality as the one in place on January 1st of that year. In other words, of the defense mechanisms of the peritoneal cavity, probably because of severe damage to the mesothelial cells. it was a mixture of incident and prevalent patients, some of whom must have been anuric. Also, the authors did As a result, peritonitis in patients who have been on CAPD for five or six years or more is much more severe not compare the relative incidence of co-morbidity. On the contrary, Fenton from the Canadian Registry studied than the peritonitis early in CAPD. I dread the threat of peritonitis in a long-term patient of mine. I am conall new patients on CAPD and on hemodialysis and found that all groups of patients-diabetics, non-diabetics, young vinced that the long-term exposure of the peritoneal membrane to unphysiologic, that is, bioincompatible, soand old-had a higher mortality rate with hemodialysis than with CAPD for at least the first three years of lutions makes an important contribution to these chronic changes. The present solutions are acidic (pH 5.5) and dialysis [114] . I believe that any method of analysis that omits, as the Bloembergen study did, the first year of hyperosmotic. The dialysis industry is under tremendous pressure to come up with new, more "peritoneal treatment for many patients will tend to show hemodialysis in a better light than peritoneal dialysis.
friendly" solutions, and I believe that within the next few years we are going to see new peritoneal solutions. Many other reasons account for the difference between the US and Canadian reports. Canadian patients In Europe they have developed and use solutions that contain, instead of glucose as the osmotic agent, a large seem to be more compliant with their treatment than are patients in the US [92] . Another big difference is that glucose polymer (Icodextrin), which achieves ultrafiltra-tion by an increased oncotic pressure instead of the inplantation in our efforts to provide our ESRD patients with the best possible renal replacement treatment. creased osmotic pressure caused by dextrose [117] . Over the long term, such solutions probably will produce ultra- 
